Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ATOMO DIAGNOSTICS LIMITED Director's Dealing 2023

Apr 17, 2023

64440_rns_2023-04-17_8eb50c7f-158c-4931-b932-ebd76ab25195.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Introduced 30/09/01 Amended 01/01/11
Name of entity Atomo Diagnostics Limited
ABN 37 142 925 684

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Curt LaBelle
Date of last notice 13 April 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct Direct Indirect Indirect
Nature of indirect interest - The Director is a controller
(including registered holder) of Global Health
Note: Provide details of the circumstances giving rise Investment Fund, LLC.
to the relevant interest.
Date of change 11 April 2023 11 April 2023
No. of securities held prior to change A. 240,000 A. 64,811,280
B. 240,000 B. 960,000
Class A. Fully paid ordinary A. Fully paid ordinary
shares shares
B. options to acquire B. options to acquire
ordinaryshares ordinaryshares
Number acquired - -
Number disposed A. - A.
B. 240,000 B. 960,000
Value/Consideration - -
Note: If consideration is non-cash, provide details
and estimated valuation
No. of securities held after change A. 240,000 Fully paid A. 64,811,280 Fully paid
ordinary shares ordinary shares
B. - B. -
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Expiry of unquoted options Expiry of unquoted options Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract n/a
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation
Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? No.
If so, was prior written clearance provided to allow thetrade to proceed during this period?
If prior written clearance was provided, on what date wasthis provided?
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011